BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34533844)

  • 1. Melatonin modulates metabolic remodeling in HNSCC by suppressing MTHFD1L-formate axis.
    Cui L; Zhao X; Jin Z; Wang H; Yang SF; Hu S
    J Pineal Res; 2021 Dec; 71(4):e12767. PubMed ID: 34533844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of the neural tube defect-associated gene
    Bryant JD; Sweeney SR; Sentandreu E; Shin M; Ipas H; Xhemalce B; Momb J; Tiziani S; Appling DR
    J Biol Chem; 2018 Apr; 293(16):5821-5833. PubMed ID: 29483189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MTHFD1L as a folate cycle enzyme correlates with prognostic outcome and its knockdown impairs cell invasive behaviors in osteosarcoma via mediating the AKT/mTOR pathway.
    Wang L; Yang Y; Wang XM; Wang CQ; Zhang YM; Li BL
    J Recept Signal Transduct Res; 2020 Dec; 40(6):584-590. PubMed ID: 32456526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma.
    Lee D; Xu IM; Chiu DK; Lai RK; Tse AP; Lan Li L; Law CT; Tsang FH; Wei LL; Chan CY; Wong CM; Ng IO; Wong CC
    J Clin Invest; 2017 May; 127(5):1856-1872. PubMed ID: 28394261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated bioinformatics analysis identified MTHFD1L as a potential biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
    Chen J; Yang J; Xu Q; Wang Z; Wu J; Pan L; Huang K; Wang C
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33605411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial C1-tetrahydrofolate synthase (MTHFD1L) supports the flow of mitochondrial one-carbon units into the methyl cycle in embryos.
    Pike ST; Rajendra R; Artzt K; Appling DR
    J Biol Chem; 2010 Feb; 285(7):4612-20. PubMed ID: 19948730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An NTD-associated polymorphism in the 3' UTR of MTHFD1L can affect disease risk by altering miRNA binding.
    Minguzzi S; Selcuklu SD; Spillane C; Parle-McDermott A
    Hum Mutat; 2014 Jan; 35(1):96-104. PubMed ID: 24123340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of Mthfd1l causes embryonic lethality and neural tube and craniofacial defects in mice.
    Momb J; Lewandowski JP; Bryant JD; Fitch R; Surman DR; Vokes SA; Appling DR
    Proc Natl Acad Sci U S A; 2013 Jan; 110(2):549-54. PubMed ID: 23267094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative analysis reveals methylenetetrahydrofolate dehydrogenase 1-like as an independent shared diagnostic and prognostic biomarker in five different human cancers.
    Sial N; Rehman JU; Saeed S; Ahmad M; Hameed Y; Atif M; Rehman A; Asif R; Ahmed H; Hussain MS; Khan MR; Ambreen A; Ambreen A
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34908119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of mitochondrial folate enzyme MTHFD1L in esophageal squamous cell carcinoma.
    Yang YS; Yuan Y; Hu WP; Shang QX; Chen LQ
    Scand J Gastroenterol; 2018 May; 53(5):533-540. PubMed ID: 29171320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabotype analysis of Mthfd1l-null mouse embryos using desorption electrospray ionization mass spectrometry imaging.
    Vaughn A; DeHoog RJ; Eberlin LS; Appling DR
    Anal Bioanal Chem; 2021 May; 413(13):3573-3582. PubMed ID: 33829277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of neural tube defect-associated gene Mthfd1l causes reduced cranial mesenchyme density.
    Shin M; Vaughn A; Momb J; Appling DR
    Birth Defects Res; 2019 Nov; 111(19):1520-1534. PubMed ID: 31518072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct effects of folate pathway genes MTHFR and MTHFD1L on ruminative response style: a potential risk mechanism for depression.
    Eszlari N; Kovacs D; Petschner P; Pap D; Gonda X; Elliott R; Anderson IM; Deakin JF; Bagdy G; Juhasz G
    Transl Psychiatry; 2016 Mar; 6(3):e745. PubMed ID: 26926881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arbutin suppresses osteosarcoma progression via miR-338-3p/MTHFD1L and inactivation of the AKT/mTOR pathway.
    Wang CQ; Wang XM; Li BL; Zhang YM; Wang L
    FEBS Open Bio; 2021 Jan; 11(1):289-299. PubMed ID: 33146000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MTHFD1L gene rs11754661 marker is not associated with Alzheimer's disease in a sample of the Spanish population.
    Ramírez-Lorca R; Boada M; Antúnez C; López-Arrieta J; Moreno-Rey C; Hernández I; Marín J; Gayán J; González-Pérez A; Alegret M; Tárraga L; Real LM; Ruiz A
    J Alzheimers Dis; 2011; 25(1):47-50. PubMed ID: 21383495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence variation at the MTHFD1L-AKAP12 and FOPNL loci does not influence multiple myeloma survival in Sweden.
    Ali M; Lemonakis K; Wihlborg AK; Veskovski L; Turesson I; Mellqvist UH; Gullberg U; Hansson M; Nilsson B
    Blood Cancer J; 2019 Jul; 9(8):57. PubMed ID: 31363079
    [No Abstract]   [Full Text] [Related]  

  • 17. Genotyping of a tri-allelic polymorphism by a novel melting curve assay in MTHFD1L: an association study of nonsyndromic Cleft in Ireland.
    Minguzzi S; Molloy AM; Peadar K; Mills J; Scott JM; Troendle J; Pangilinan F; Brody L; Parle-McDermott A
    BMC Med Genet; 2012 Apr; 13():29. PubMed ID: 22520921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic Ras expression increases cellular formate production.
    Pongnopparat T; Tingley G; Gao Y; Brosnan JT; Brosnan ME; Christian SL
    Amino Acids; 2021 Oct; 53(10):1589-1595. PubMed ID: 34550462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hnRNPC regulates cancer-specific alternative cleavage and polyadenylation profiles.
    Fischl H; Neve J; Wang Z; Patel R; Louey A; Tian B; Furger A
    Nucleic Acids Res; 2019 Aug; 47(14):7580-7591. PubMed ID: 31147722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphism rs6922269 in the MTHFD1L gene is associated with survival and baseline active vitamin B12 levels in post-acute coronary syndromes patients.
    Palmer BR; Slow S; Ellis KL; Pilbrow AP; Skelton L; Frampton CM; Palmer SC; Troughton RW; Yandle TG; Doughty RN; Whalley GA; Lever M; George PM; Chambers ST; Ellis C; Richards AM; Cameron VA
    PLoS One; 2014; 9(3):e89029. PubMed ID: 24618918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.